|
2024
|
Invention
|
Proteolysis-targeting chimeras. LabLLLL is a group of formula (H1). The compounds are useful as p... |
|
2023
|
Invention
|
Protacs useful against the main protease sars-cov-2. PL2LL comprises an E3 ubiquitin ligase ligan... |
|
|
Invention
|
Proteolysis-targeting chimeras against the papain-like protease of sars-cov-2. L21LL comprises an... |
|
2022
|
Invention
|
Method for staining mitochondria.
Methods for staining mitochondria are disclosed involving usin... |
|
|
Invention
|
Azetidine substituted rosamines useful for staining mitochondria.
Azetidine substitute rosamines... |
|
|
Invention
|
Azetidine substituted rosamines useful for staining mitochondria. 2121213141314131421313 and epox... |
|
|
Invention
|
Method for staining mitochondria. 2121213141314131414. Also disclosed are methods for analysing m... |
|
2002
|
G/S
|
Chemicals; radiochemicals; radioligands; neurochemicals;
signal transduction agents; peptides; b... |
|
1996
|
Invention
|
Alpha-cyclopropyl-substituted phenylglycines as cns agents. Compounds of formula (I) are provided... |
|
1994
|
Invention
|
Aryl substituted amino acids, cns influencing agents. Compounds of formula (I) are disclosed, whe... |
|
|
Invention
|
Alpha-quaternary-alpha-amino acids for use as cns agents. Compounds of formula (I) are disclosed ... |
|
|
Invention
|
Alkylamino substituted triazinediones, triazinemonothiones and triazinedithiones. There is provid... |
